Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies

This study has been completed.
Information provided by (Responsible Party):
Reata Pharmaceuticals, Inc. Identifier:
First received: September 12, 2007
Last updated: November 4, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)